Federal contractor profile
BASILEA PHARMACEUTICA INTERNATIONAL LTD, ALLSCHWIL
UEI UA43HWRNXFS3CAGE SSU10Company website ↗
Active
Overview
- Legal name
- BASILEA PHARMACEUTICA INTERNATIONAL LTD, ALLSCHWIL
- Also known as
- BASILEA PHARMACEUTICA INTERNATIONAL SA, ALLSCHWIL
- Registered location
- ALLSCHWIL, CHE
- Website
- Company website ↗
- Primary NAICS
- 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
- Latest award activity
- Aug 4, 2026
Read company summary
BASILEA PHARMACEUTICA INTERNATIONAL LTD, ALLSCHWIL is associated with UEI UA43HWRNXFS3 and CAGE SSU10 in public federal records. AcornBids currently links 4 prime awards totaling $291.4M in obligations to this entity. Its largest recorded federal customer by obligations is Department of Health and Human Services. Its recorded federal awards include work classified as Research and Development in Biotechnology (except Nanobiotechnology). These categories describe the loaded award records, not a complete list of company capabilities. Its primary SAM.gov NAICS is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)). Its public SAM.gov registration lists ALLSCHWIL, CHE.
At a glance
Lifetime prime obligations$291.4M
Prime awards4
Awards with future end dates2
Top-agency concentration
Not available
Why this customer concentration
Detailed agency totals are not available in this stored profile.
Largest positive coded-agency total ÷ all positive coded-agency totals × 100
Missing data is shown as unavailable.
Prime contract obligations across loaded award records. Obligations are not revenue or contract ceilings. Summary updated Sep 28, 2026. Refresh pending; these totals may be out of date.
Business information
Public SAM.gov registration details.
- Legal name
- BASILEA PHARMACEUTICA INTERNATIONAL LTD, ALLSCHWIL
- Doing business as
- BASILEA PHARMACEUTICA INTERNATIONAL SA, ALLSCHWIL
- UEI
- UA43HWRNXFS3
- CAGE
- SSU10
- Registered address
- HEGENHEIMERMATTWEG 167B, ALLSCHWIL, 4123, CHE
- Registration status
- Active
- Primary NAICS
- 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
- SAM activation
- Mar 10, 2026
- Initial registration
- Feb 8, 2013
- Entity start
- Mar 19, 2008
- SAM updated
- Mar 10, 2026
- Registration expires
- Mar 10, 2027
- Fiscal year end
- Dec 31
- Place of incorporation
- CHE
Federal award analysis
Net transaction obligations by federal fiscal period.
Transaction history is not available in the loaded data. Annual funding is not estimated from current award totals.
Recent federal awards
Prime contract awards. Select an award to review its history and source evidence.
| Award / description | Awarding agency | Obligations | Start date | End date |
|---|---|---|---|---|
| 75A50123C00050VENATORX PHARMACEUTICALS: NEW ANTIBIOTICS TO TREAT DRUG-RESISTANT GRAM-NEGATIVE BACTERIA INCLUDING PUBLIC HEALTH PATHOGENS. | Department of Health and Human Services | $45.2M | Sep 15, 2023 | Dec 31, 2029 |
| 75A50124C00033THE DEVELOPMENT OF ANTIMICROBIALS FOR THE TREATMENT OF RESISTANT FUNGAL AND BACTERIAL INFECTIONS - OTA | Department of Health and Human Services | $122.5M | Sep 30, 2024 | Dec 31, 2035 |
| HHSO100201600002CIGF::OT::IGF ADVANCED DEVELOPMENT OF CEFTOBIPROLE | Department of Health and Human Services | $110.6M | Apr 19, 2016 | Apr 18, 2026 |
| HHSO100201300010CIGF::OT::IGF FOR OTHER FUNCTIONS THIS CONTRACT IS FOR THE CLINICAL DEVELOPMENT OF BAL30072, A NOVEL MONOSULFACTAM FOR THE TREATMENT OF INFECTIONS CAUSED BY MULTI-DRUG RESISTANT… | Department of Health and Human Services | $13.1M | Jun 19, 2013 | Jun 1, 2019 |
Upcoming positioning windows
Modeled recompete windows are estimates, not announced solicitations or guarantees.
Registration, certifications & contacts
| Registration evidence | Date |
|---|---|
| SAM updated | Mar 10, 2026 |
| Source loaded | Sep 26, 2026 |
| Initial registration | Feb 8, 2013 |
| Entity start | Mar 19, 2008 |
| Industry | Reported size status |
|---|---|
| 541714 — Research and Development in Biotechnology (except Nanobiotechnology) | Not reported |
| 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | Not reported |
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| MARK JONES | Government business | Contact method not published | SAM registration | Not available |
| GUY MAGGAY | Electronic business | Contact method not published | SAM registration | Not available |
Registered industries
- 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
- 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Registered products and services
- AN13 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT
Registration classifications and published certificates do not by themselves establish eligibility for a particular solicitation. View SAM source
Related companies worth researching
Explore the customer, work and award-size evidence behind each match.
49 awards
26 awards
25 awards
20 awards
18 awards
16 awards
15 awards
About BASILEA PHARMACEUTICA INTERNATIONAL LTD, ALLSCHWIL
What products and services appear in its federal awards?
Recorded award industries: 541714 — Research and Development in Biotechnology (except Nanobiotechnology); 541711.
Recorded products and services: AN13 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT; AN42 — HEALTH R&D SERVICES; HEALTH CARE - OTHER; APPLIED RESEARCH.
Examples from recent award records:
- VENATORX PHARMACEUTICALS: NEW ANTIBIOTICS TO TREAT DRUG-RESISTANT GRAM-NEGATIVE BACTERIA INCLUDING PUBLIC HEALTH PATHOGENS.
- THE DEVELOPMENT OF ANTIMICROBIALS FOR THE TREATMENT OF RESISTANT FUNGAL AND BACTERIAL INFECTIONS - OTA
These records describe federal award work, not every company capability. Review the award evidence.
Where is the company registered?
HEGENHEIMERMATTWEG 167B, ALLSCHWIL 4123, CHE
Registered location from SAM.gov; award performance locations may differ.
What is its primary registered industry?
541714 — Research and Development in Biotechnology (except Nanobiotechnology).
Primary SAM.gov NAICS classification.
Which federal agencies are represented in its awards?
Department of Health and Human Services.
Data coverage and methodology
Sources: SAM.gov registration, USAspending awards and transactions, and linked supporting records. Prime contract obligations, IDV ceilings and assistance amounts are kept separate. Missing records are not zero activity. Company claims are labeled separately. Recompete signals are rule-based scores out of 100. Positioning windows are AcornBids estimates.
No official subaward rows are loaded, so Acorn does not claim known teaming relationships.
Recently viewed companies
Keep your research moving
Save this company, track changes, and evaluate upcoming work against your targets.
Save to my research Find my fit